ENA-001 for Post Operative Respiratory Depression (PORD)
Status:
Not yet recruiting
Trial end date:
2025-09-15
Target enrollment:
Participant gender:
Summary
This study is a Phase II, randomized, placebo-controlled, double-blind trial in 200 subjects
having general anesthesia for major elective surgery with postoperative pain management to
evaluate the efficacy, safety and tolerability of ENA-001 as a therapy to prevent post
operative respiratory depression.